Avid Radiopharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVID RADIOPHARMS INC, and when can generic versions of AVID RADIOPHARMS INC drugs launch?
AVID RADIOPHARMS INC has two approved drugs.
There are three US patents protecting AVID RADIOPHARMS INC drugs.
There are sixty-three patent family members on AVID RADIOPHARMS INC drugs in thirty-four countries and sixteen supplementary protection certificates in sixteen countries.
Summary for Avid Radiopharms Inc
| International Patents: | 63 |
| US Patents: | 3 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Avid Radiopharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avid Radiopharms Inc | TAUVID | flortaucipir f-18 | SOLUTION;INTRAVENOUS | 212123-002 | May 28, 2020 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-002 | Apr 6, 2012 | DISCN | Yes | No | 8,506,929 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Avid Radiopharms Inc | TAUVID | flortaucipir f-18 | SOLUTION;INTRAVENOUS | 212123-004 | Jul 1, 2022 | RX | Yes | Yes | 8,932,557 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Avid Radiopharms Inc | TAUVID | flortaucipir f-18 | SOLUTION;INTRAVENOUS | 212123-001 | May 28, 2020 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-003 | Apr 6, 2012 | RX | Yes | Yes | 8,506,929 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Avid Radiopharms Inc Drugs
Supplementary Protection Certificates for Avid Radiopharms Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1999109 | C01999109/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: FLORBETAPIR (18F); REGISTRATION NO/DATE: SWISSMEDIC 62897 09.01.2014 |
| 1999109 | 92232 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: FLORBETAPIR (18 F) |
| 1999109 | C 2013 023 | Romania | ⤷ Sign Up | PRODUCT NAME: FLORBETAPIR(18F)4-[(1E)-2-(6-{2-[2-(2-[18F]FLUOROETOXI)ETOXI]ETOXI}PIRIDIN-3-IL)ETENIL]-N-METILBENZENAMINA; NATIONAL AUTHORISATION NUMBER: EU/1/12/805; DATE OF NATIONAL AUTHORISATION: 20130114; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/12/805; DATE OF FIRST AUTHORISATION IN EEA: 20130114 |
| 1999109 | 481 | Finland | ⤷ Sign Up | |
| 1999109 | 2013/028 | Ireland | ⤷ Sign Up | PRODUCT NAME: FLORBETAPIR (18F), OPTIONALLY IN THE FORM OF PHARMACEUTICALLY ACCEPTABLE SALT; REGISTRATION NO/DATE: EU/1/12/805 20130114 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
